Midgard Science

Labs / ADME, DMPK & toxicology

Ability Biotherapeutics

Montreal, QC, Canada · ability.bio

On your own

Free. Their own form.

Contact Ability Biotherapeutics directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Ability Biotherapeutics develops fully-human therapeutic antibodies using its AbiLeap discovery engine. It is developing antibody candidates for autoimmune and inflammatory diseases, including a lead preclinical immune cell depleter for inflammatory skin diseases.

Their website has a general contact form; we send your quote request through it.

What they offer

  • AbiLeap discovery engine

    Uses massively parallel, continuously learning artificial intelligence and a proprietary database of therapeutic antibody sequences and antigen-antibody interactions to generate fully-human antibodies.

  • Antibody engineering for selectivity and specificity

    Engineers conventional IgGs for properties such as dual specificity, metabolite sensing, or rare epitope binding.

  • Monospecific antibody candidate development

    Develops monospecific antibody candidates with selectivity for specific immune cell subpopulations.

What they work on

Modalities
Small molecule, Antibody
Therapeutic areas
autoimmune diseases, inflammatory diseases, inflammatory skin diseases
Address
2025 Announcement Dr. Elizabeth Quackenbush appointed Chief Medical Officer Read more Sept
Founded
2010

Similar labs. Aclairo Pharmaceutical Development Group, Inc., ACM Global Laboratories, Allumiqs, AxisPharm

Found in a contract services directory. Listing built from ability.bio. Work here? Claim this listing.

Ability Biotherapeutics · Midgard Science